NEUROPEDIATRICS, vol.46, no.5, pp.313-320, 2015 (SCI-Expanded)
Objectives The purpose of this study was to characterize patients who were diagnosed with glucose transporter protein 1 deficiency syndrome (Glut1D), and also to assess the efficacy of ketogenic diet (KD) therapy on seizure control, cognitive functions, and other neurological disorders.